Discover 7 unexpected causes of bleeding gums beyond gingivitis. Learn the surprising health conditions that trigger gum ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

New research by Swansea University and Cambridge University has revealed the causes and devastating impacts of delays—that ...

There are multiple chapters near you. Select your preferred chapter.

Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.

Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve ...

Dysregulation of the alternative complement pathway, hallmarked by isolated reduction of the serum C3 fraction, is now recognized as an additional feature of lupus nephritis.

By contrast, the presence of antiphospholipid antibodies or lupus anticoagulant could not reliably predict the time of clotting, ... Hence, the D-dimer assay is potentially useful in the management of ...

GSK (GSK) plc announced that the U.S. Food and Drug Administration has approved a 200 mg/mL autoinjector of Benlysta, a B-lymphocyte ...

New research by Swansea University and the University of Cambridge has revealed the causes and devastating impacts of delays – that can last decades - in diagnosing lupus, an auto-immune condition.

Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupus ...

Results SLE-related risk factors for each model included mean disease activity score (as measured by the SELENA revision of the SLE Disease Activity Index), low C3 and history of lupus anticoagulant.